• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Three questions to Anthony, Principal Consultant at NHTA!

The NHTA team is now recharged after a very sunny trip to Lund for SHEA!

๐–๐žโ€™๐ซ๐ž ๐ก๐ข๐ซ๐ข๐ง๐  ๐š ๐’๐ญ๐ฎ๐๐ž๐ง๐ญ ๐€๐ฌ๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐ญ ๐ข๐ง ๐‡๐„๐Ž๐‘ & ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐œ๐œ๐ž๐ฌ๐ฌ!

Weโ€™re excited to join SHEA this week in Lund!

We are pleased to announce the engagement of Emma Medin, PhD, MD, as Senior Advisor to NHTA

NICE and MHRA align reviews to speed access

Denmark consults on reimbursement status for cancer medicines

Danish quality institute schedules 2026 guideline webinars

Danish Medicines Council appraised 84 new medicines in 2025

Region Midtjylland appoints new member to Medicinrรฅdet

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allรฉ 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy